New cancer vaccine shrunk 54% of tumors in NIH clinical trial
A new shot supercharges late-stage cancer patients' own immune systems to stop the growth of tumors that other treatments failed to slow, a new small National Institutes of Health trial revealed.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Clinical Trials | Health | National Institutes of Health (NIH) | Vaccines